SOBR Stock Catalyst: SOBR Safe Granted European Patent for Noninvasive Transdermal Alcohol Screening System

SOBR Safe, Inc. announced it has been granted a European patent for its noninvasive transdermal alcohol screening system. The patent, which bolsters the company's intellectual property portfolio, was awarded following a rigorous examination process.

The new patent covers SOBR Safe's innovative technology designed to detect alcohol levels through the skin without the need for invasive procedures. This advancement is expected to support the company's expansion into European markets.

As of the latest company context, SOBR Safe has a free float of 1,215,200 shares and 1,516,200 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.